A Clinical Evaluation of the TK 210 ELISA in Sera From Breast Cancer Patients Demonstrates High Sensitivity and Specificity in All Stages of Disease
Tumor Biology - United States
doi 10.1007/s13277-016-5024-z
Full Text
Open PDFAbstract
Available in full text
Date
April 14, 2016
Authors
Publisher
Springer Science and Business Media LLC